Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

M Hindle, D A Newton, H Chrystyn

School of Pharmacy, University of Bradford, West Yorkshire.

BACKGROUND--A simple non-invasive method, in which a urine sample is taken 30 minutes after drug administration, has previously been shown to be a measure of the relative bioavailability of salbutamol to the lungs. This technique has been used to determine an optimal inhaler technique with commercially available metered dose inhalers (MDI). METHODS--Ten healthy subjects were trained in the use of MDIs. Each inhaled 4 x 100 micrograms salbutamol in a series of experiments to examine the relative bioavailability to the lung after different respiratory manoeuvres. Urine collection intervals were 0-0.5 hours and 0.5-24 hours after administration. RESULTS--There was significantly greater elimination of unchanged salbutamol 30 minutes after administration, indicating a greater relative bioavailability of salbutamol to the lungs after (1) exhaling gently to residual volume rather than to functional residual capacity before inhalation; (2) slow inhalation (10 l/min) compared with fast inhalation (50 l/min); (3) breath holding for 10 seconds after inhalation compared with no breath holding. CONCLUSIONS--All patient information leaflets and healthcare personnel should standardise the instructions given to patients and should adopt the inhalation method proposed.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Al-Showair, R. A.M., Pearson, S. B., Chrystyn, H. (2007). The Potential of a 2Tone Trainer To Help Patients Use Their Metered-Dose Inhalers. Chest 131: 1776-1782 [Abstract] [Full Text]  
• Newman, S. P. (2005). Inhaler treatment options in COPD. ERR 14: 102-108 [Abstract] [Full Text]  
• Ind, P. W. (2005). Bigger May Be Better: Targeted {beta}2-Agonist Therapy. Am. J. Respir. Crit. Care Med. 172: 656-657 [Full Text]  
• Usmani, O. S., Biddiscombe, M. F., Nightingale, J. A., Underwood, S. R., Barnes, P. J. (2003). Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J. Appl. Physiol. 95: 2106-2112 [Abstract] [Full Text]  
• Stewart, B. A., Ahrens, R. C., Carrier, S., Frosolono, M., Lux, C., Han, S.-H., Milavetz, G. (2000). Demonstration of In Vivo Bioequivalence of a Generic Albuterol Metered-Dose Inhaler to Ventolin. Chest 117: 714-721 [Abstract] [Full Text]  
• Nelson, H. S. (1995). {beta}-Adrenergic Bronchodilators. NEJM 333: 499-507 [Full Text]